Summary
The new nonsteroidal antiinflammatory drug (NSAID) arylacetic amfenac (2-amino-3-benzoylphenylacetic acid) and 19 substituted derivatives were studied in order to correlate the biological activities with the structure-related parameters.
The geometry of amfenac in neutral and anionic form was totally optimized, starting from standard geometries and crystallographic data, using semiempirical AM1 and MNDO quantum-mechanical methods. Conformational analysis shows the existence of a rigid structure for rotations of the acetic acid chain (α°) and the central carbonyl group (γ°) around the bonds with the phenylamine ring, whereas the carboxyl group (β°) and the phenyl ring of the benzoyl group (δ°) can rotate almost freely.
Electrostatic potential maps were analyzed and showed that the electrostatic orientation effect seems to make an important contribution to the binding of the active compounds to prostaglandin synthase. An electrostatic orientation model of the binding site is proposed. The frontier orbital charge distribution was also described for each compound. On the other hand, steric, electronic and hydrophobic (log P) parameters were calculated and QSAR analysis showed that the most significant parameter for the antiinflammatory activity was the π-electron density of the HOMO orbital in the second aromatic ring. These results suggest a possible electronic charge transfer between the aromatic fragments and the receptor.
Similar content being viewed by others
References
Welstead Jr., W.J., Moran, H.W., Stanffer, H.F., Turnbull, L.F. and Sancilio, L.F., J. Med. Chem., 22 (1979) 1074.
Walsh, D.A., Shamblee, D.A., Uwaydah, I.M., Welstead Jr., W.J., Sancilio, L.F. and Dannenburg, W.N., J. Med. Chem., 27 (1984) 1379.
Sancilio, L.F., Reese, D.L., Cheunz, S. and Alphin, R.S., Agents Actions, 7 (1977) 133.
Okazaki, T., Kosaka, S., Mitomo, N., Kasukawa, R. and Nishimagi, T., Clin. Rep., 16 (1982) 6514.
Kawano, K. and Kimura, G., Clin. Rep., 16 (1982) 6683.
Hiranuma, T., Kato, S. and Hachisu, M., J. Pharmacobiodyn., 11 (1988) 612.
Walsh, D.A., Moran, H.W., Shamblee, D.A., Welstead Jr., W.J., Nolan, J., Sancilio, L.F. and Graff, G., J. Med. Chem., 33 (1990) 2296.
Vane, J.R. and Botting, R., FASEB J., 1 (1987) 89.
Gund, P. and Shen, T.Y., J. Med. Chem., 20 (1977) 1146.
Salvetti, F., Buttinoni, A., Ceserani, R. and Tosi, C., Eur. J. Med. Chem., 16 (1981) 81.
Appleton, R.A. and Brown, K., Prostaglandins, 18 (1979) 29.
Nicholson, R.M., Murphy, J.R. and Dearden, J.C., J. Pharm. Pharmacol., 34 (1982) 106P.
Mehler, E.L. and Gerhards, J., Int. Quantum Chem., 35 (1989) 205.
Kulmacz, K.J., J. Biol. Chem., 264 (1989) 14136.
Miyamoto, T., Ogino, N., Yamamoto, S. and Hayaishi, O., J. Biol. Chem., 251 (1976) 2629.
Van der Ouderaa, F.J., Buytenhek, M., Nugteren, D.H. and Van Dorp, D.A., Biochim. Biophys. Acta, 487 (1977) 315.
Yokoyama, C., Toh, H., Miyata, A. and Tanabe, T., Adv. Prostaglandins, Thromboxane, Leukotriene Res., 21 (1990) 61.
Toh, H., FEBS Lett., 258 (1989) 317.
Smith, W.L., DeWitt, D.L., Kraemer, S.A., Andrews, M.J., Hla, T., Maciag, T. and Shimokawa, T., Adv. Prostaglandin Thromboxane Leukotriene Res., 20 (1990) 14.
Smith, W.L. and Marnett, L.J., Biochim. Biophys. Acta, 1083 (1991) 1.
Smith, W.L., Marnett, L.J. and DeWitt, D.L. In Taylor, C.W. (Ed.), Pharmacology and Therapeutics, Pergamon Press, New York, 1991, 153–179.
Bekemeier, H., Böhm, R., Hagen, V., Hanning, E., Henkel, H.J., Hirschelmann, R. and Wenzel, U., Agents Actions, Suppl. (1982) 17.
Kuchar, M., Resholec, V. and Nemecek, O., Drugs Future, 7 (1982) 179.
Dearden, J.C., Gregg, C.N. and Nicholson, R.M., In Fauchère, J.L. (Ed.) QSAR: Quantitative Structure-Activity Relationships in Drug Design, Alan R. Liss, New York, 1989, pp. 353–356.
Ruiz, J., López, M., Milà Lozoya, E. and Pouplana, R., In Silipo, C. and Vittoria, A. (Eds.) QSAR: Rational Approaches to the Design of Bioactive Compounds, Elsevier Science Publishers, Amsterdam, 1991, pp. 477–480.
Moser, P., Sallmann, A. and Wiesenberg, I., J. Med. Chem., 33 (1990) 2358.
Muchowski, J.M., Unger, S.H., Ackrell, J., Cheung, P., Cooper, G.F., Cook, J., Gallegra, P., Halpern, O., et al., J. Med. Chem., 28 (1985) 1037.
López, M., Ruiz, J., Milà, J., Lozoya, E. and Pouplana, R., In Silipo, C. and Vittoria, A. (Eds.) QSAR: Rational Approaches to the Design of Bioactive Compounds. Elsevier Science Publishers, Amsterdam, 1991, pp. 315–318.
Kennard, C.H., Smith, G. and White, A.H., Acta Crystallogr., B37 (1981) 1317.
Bats, J.W. and Cannenbley, R., Acta Crystallogr., C40 (1984) 995.
Allen, F.H., Kennard, O. and Taylor, R., Acc. Chem. Res., 16 (1983) 146.
Dewar, M.J.S. and Thiel, W., J. Am. Chem. Soc., 99 (1977) 4899.
Dewar, M.J.S., Zoebisch, E.G., Healy, E.F., and Stewart, J.J.P., J. Am. Chem. Soc., 107 (1985) 3902.
Olivella, S., Q.C.P.E. Bull., 9 (1984) 109. Modified by Olivella, S. and Bofill, J.M. in 1987.
Stewart, J.J.P., Q.C.P.E. Bull., 3 (1983) 101.
BIOSYM Technologies, Inc., 10065 Barnes Canyon Road, San Diego, CA 92121.
Orozco, M. and Luque, F.J., J. Comput.-Aided Mol. Design, 4 (1990) 411.
Luque, F.J. and Orozco, M., Chem. Phys. Lett., 168 (1990) 269.
Luque, F.J., Orozco, M. and Illas, F., unpublished results.
DIMA computer program was made by the Pisa group and was provided by Dr. M. Cimiraglia at the Università di Pisa.
Roberson, W., ApSimon, J.W. and Herman, L., Q.C.P.E. Bull., 7 (1987) 88.
Statgraphics, Statistical Graphic Systems, STSS Inc., 2115 East Jefferson Street, Rockville, MD 20852, 1986.
Boyd, D.B. and Smith, D.W., J. Comput. Chem., 9 (1988) 387.
Dive, G., Lapière, C.L. and Leroy, G., Bull. Soc. Chim. Belg., 86 (1977) 73.
Smeyers, Y.G., Cuellar, S., Galvez, E. and Arias, M.S., J. Pharm. Sci., 74 (1985) 47.
Smeyers, Y.G., Hernandez, A., Muñoz, C., Aguilera, J., Galvez, E. and Arias, M.S., J. Pharm. Sci., 78 (1989) 764.
Hansch, C. and Fujita, T., J. Am. Chem. Soc., 86 (1964) 1616.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ruiz, J., López, M., Milà, J. et al. QSAR and conformational analysis of the antiinflammatory agent amfenac and analogues. J Computer-Aided Mol Des 7, 183–198 (1993). https://doi.org/10.1007/BF00126444
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00126444